Approval · Notice of Compliance 13442 · 2012
BANZEL: Notice of Compliance 13442
Issued June 28, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13442
- Date
- June 28, 2012
- Company
- Eisai LimitedWoodcliff Lake, New Jersey, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antiepileptic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANZEL | 02388685 | Cancelled Pre Market |
Medicinal ingredients
- RUFINAMIDE 40 MG per ML